Results 151 to 160 of about 10,835,507 (313)

Flummoxed by the flaps - case report. [PDF]

open access: yesBMC Geriatr
Pahwa B, Tasir PK, Sequeira RS, Khade M.
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Recurrent Bilateral Pleural Effusion Secondary to Idiopathic Pleuritis in a Young Female Patient

open access: yesTranslation, 2023
Muzdah Anwar   +7 more
doaj   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Persistent Skin Eruption in a Renal Transplant Patient

open access: yesTranslation, 2023
Omar Abdul-Aziz   +3 more
doaj   +1 more source

Carrington's Disease: A Case Report. [PDF]

open access: yesCureus
Bouali S   +4 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

A prolonged presentation of cyclic vomiting syndrome in an adult

open access: yesTranslation, 2023
Audrey Ballard, Andrew Campbell
doaj   +1 more source

Fitz Hugh Curtis Case Report [PDF]

open access: yes, 2020
Bitter, Cindy, Loehr, Savannah
core  

Home - About - Disclaimer - Privacy